Surmodics | SRDX - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Align Technology USD 12.28B 1.07B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Artivion USD 2.18B 176M 2025-12
Baxter International USD 8.67B 1.15B 2026-03
Boston Scientific USD 93.26B 48.09B 2026-03
EDAP TMS EUR 73M 11M 2025-09
Edwards Lifesciences USD 46.17B 3.3B 2026-03
Haemonetics USD 3.76B 1.44B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
J&J USD 579.15B 78.91B 2026-03
Merit Medical Systems USD 4.11B 1.11B 2026-03
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Option Care Health USD 4.23B 831M 2026-03
Stryker USD 125.85B 8.57B 2026-03